When Your Doctor Says "You're Too Young for That" and You're Not

There is a particular kind of frustration that comes from knowing something is wrong with your body and being told, essentially, that you are being unreasonable for worrying about it. For young adults with early colorectal cancer symptoms, this experience is not anecdotal. It is epidemiological. Research consistently shows that people under 50 who are eventually diagnosed with colorectal cancer experience longer diagnostic delays, see more providers before getting the right diagnosis, and are more likely to be initially misdiagnosed with a benign condition. The reasons for this are understandable on the provider side, but the consequences fall entirely on the patient side. This article is about understanding why dismissal happens and what you can do about it without blowing up your relationship with your doctor.

How long does it take for young adults with colorectal cancer to get diagnosed?

The data on diagnostic delay in young-onset CRC is remarkably consistent across studies and countries. A systematic review published in the Journal of Surgical Oncology found that patients under 50 with colorectal cancer experienced an average of 4 to 6 months from symptom onset to diagnosis (Abdelsattar et al., 2016). Some studies report even longer intervals. A UK analysis of diagnostic pathways found that the median time from first GP presentation to diagnosis for patients under 50 was significantly longer than for patients over 50, even after adjusting for symptom type (Lyratzopoulos et al., 2015).

A study published in Clinical Gastroenterology and Hepatology reported that young-onset CRC patients visited an average of 2 to 3 healthcare providers before receiving the correct diagnosis. Nearly half reported that their initial symptoms were attributed to a benign condition without diagnostic investigation (Scott et al., 2016). The Colorectal Cancer Alliance's survey data found similar patterns, with many patients reporting that their symptoms were dismissed or minimized during initial encounters.

These delays have consequences. Multiple studies have demonstrated a correlation between longer diagnostic intervals and more advanced staging at diagnosis. While not every study shows a statistically significant link between delay and survival outcomes (the relationship is complicated by lead-time bias and other factors), later-stage diagnosis universally means more intensive treatment and worse average prognoses.

Why do doctors dismiss colorectal cancer symptoms in young adults?

It is tempting to frame this as negligence, but the reality is more nuanced. Clinicians are trained to think probabilistically, and the base rate of colorectal cancer in young adults is genuinely low. When a 30-year-old presents with rectal bleeding, hemorrhoids are overwhelmingly the most likely diagnosis. When a 25-year-old reports bloating and altered bowel habits, IBS or dietary causes are statistically far more common than cancer. Probability-based reasoning is usually correct. But 'usually' is not 'always.'

Several specific cognitive patterns contribute to the dismissal problem. Anchoring bias leads providers to lock onto the first plausible explanation (hemorrhoids, IBS) and underweight subsequent information that might challenge it. Age heuristic causes providers to use the patient's age as a proxy for risk, which is reasonable as a starting point but can become a barrier to further evaluation. Diagnostic momentum means that once a benign diagnosis is recorded in a chart, subsequent providers may accept it without independent reassessment.

There are also system-level factors. Primary care visits are often short, averaging 15 to 20 minutes. Discussing the possibility of colorectal cancer in a young patient, ordering appropriate tests, and navigating referral pathways takes more time than prescribing hemorrhoid cream. Insurance and referral requirements can add friction to the diagnostic process. And in some settings, colonoscopy for a young patient without a 'qualifying' indication may face utilization review pushback.

What is the difference between appropriate reassurance and inappropriate dismissal?

This distinction is important and sometimes blurry. Not every case of a doctor saying 'I do not think this is cancer' is a dismissal. Sometimes it is appropriate clinical judgment. The difference lies in the reasoning, the examination, and the follow-up plan.

Appropriate reassurance typically includes a thorough history taking (asking about duration, character of symptoms, family history, associated symptoms), a physical examination (including a digital rectal exam), consideration of red flag symptoms, and either a clear explanation of why further testing is not needed or a specific follow-up plan ('If this does not resolve in 4 weeks, come back and we will escalate').

Inappropriate dismissal looks different. It often involves minimal history taking, no physical examination of the relevant area, dismissal based primarily on the patient's age ('You are too young for that'), no discussion of what would warrant return or escalation, and in some cases, no follow-up plan at all. If you leave an appointment feeling like your symptoms were not heard, and there is no plan for what happens if they continue, that is a signal worth paying attention to.

What should you say to your doctor if you are concerned about colorectal cancer?

Specific language can make a significant difference. The goal is to communicate clearly, show that you are informed, and make it easy for your provider to take the appropriate next step. Here are practical approaches that have been recommended by patient advocacy organizations and clinicians who specialize in young-onset CRC.

Start by describing your symptoms specifically and with a timeline. 'I have had rectal bleeding roughly three times a week for the past six weeks. My bowel habits have also changed. I used to go once daily and now I am going three to four times with loose stools. I have also lost about 8 pounds without trying.' This is more actionable than 'I have been having stomach problems.'

Name the concern directly. 'I know colorectal cancer is rising in young adults, and I am concerned that my symptoms could be related.' This is not self-diagnosing. It is asking your provider to consider a specific differential diagnosis. Clinicians respond to direct clinical questions differently than to vague worry.

Ask what is being ruled out and how. 'What diagnoses are you considering? What would we need to do to rule out the serious ones?' If the answer is hemorrhoids, the follow-up is: 'How are we confirming that? Would a referral for a colonoscopy be appropriate given the duration of my symptoms?'

If a test or referral is declined, ask for the reasoning and documentation. 'I understand that you do not think a colonoscopy is indicated right now. Can you help me understand what criteria you are using? And can you document in my chart that I requested this evaluation and the reasoning for the decision?' This is not a threat. It is a reasonable request for medical record accuracy that also creates accountability.

When should you seek a second opinion?

Seeking a second opinion is not an insult to your doctor. It is a standard part of navigating medical care for any persistent, concerning symptom. The following situations are reasonable triggers for a second opinion, particularly from a gastroenterologist if you have been seeing only a primary care provider.

When seeking a second opinion, request a copy of your medical records from the initial evaluation. This saves time and prevents the new provider from inadvertently being anchored by a phone summary. A gastroenterologist will assess your symptoms independently and can order colonoscopy directly.

How can you document your symptoms to support your case?

The single most effective thing you can bring to a medical appointment is data. A clear, organized symptom timeline transforms a vague complaint into a clinical pattern. Track the following: date and nature of each symptom episode (bleeding, pain, bowel changes), frequency and duration, severity on a consistent scale, any associated symptoms (weight change, fatigue, appetite), and what you have already tried (dietary changes, OTC treatments, prior prescriptions).

Tools like GLP1Gut can help you track symptoms and bring organized data to your doctor, which is particularly useful when the concern is a pattern over weeks or months rather than an acute event. Having this information already compiled means you do not lose valuable appointment time trying to reconstruct a timeline from memory.

Clinicians are trained to recognize patterns, but they can only work with the information presented during a visit. A patient who says 'I have had rectal bleeding on and off' conveys less clinical information than a patient who says 'I have had 14 episodes of rectal bleeding in the past 8 weeks, the blood is bright red and mixed into the stool, and my bowel habits shifted from once daily to three times daily with urgency starting around the same time.' The second description is harder to dismiss.

What about disparities in who gets dismissed?

The diagnostic delay problem does not affect all young adults equally. Research on disparities in cancer diagnosis has consistently shown that women, Black patients, and patients from lower socioeconomic backgrounds experience longer diagnostic intervals for many cancer types, including colorectal cancer (Morris et al., BMJ, 2023).

For colorectal cancer specifically, a study in JAMA Network Open found that Black patients under 50 were diagnosed at later stages on average compared to white patients of the same age, even after accounting for insurance status (Holowatyj et al., 2020). Whether this is driven by differences in access, provider behavior, or patient-level factors is an active area of investigation. The practical implication is that if you belong to a group that faces additional barriers to being heard in medical settings, the advocacy strategies described above become even more important.

The bottom line on navigating dismissal

Being told 'you are too young for that' is not a medical test. It is a heuristic, and while it is often correct, it is not a substitute for clinical evaluation of persistent, concerning symptoms. The diagnostic delay in young-onset CRC is a well-documented, consequential problem, and you are not being a difficult patient by insisting that your symptoms be taken seriously.

At the same time, the goal is collaborative, not combative. Most providers genuinely want to help their patients. Sometimes the issue is time constraints, system friction, or an honest difference in risk assessment. Clear communication, organized data, specific questions, and a willingness to seek additional input when needed are your best tools for navigating a system that was not designed with young-onset CRC in mind.